Sundaram Multi Pap Ltd
NSE: SUNDARAM BSE: 533166
₹1.39
(0%)
Mon, 25 May 2026, 07:59 am
Market Cap663.43M
PE Ratio57.20
Dividend0
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Sundaram Multi Pap Analysis
dividend
Pros
Cons
- Unable to calculate sustainability of dividends as Sundaram Multi Pap has not reported any payouts.
- Unable to evaluate Sundaram Multi Pap's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Sundaram Multi Pap's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
- Sundaram Multi Pap is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Sundaram Multi Pap is profitable, therefore cash runway is not a concern.
- Sundaram Multi Pap is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (22.3%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2x debt.
- Sundaram Multi Pap's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (101.7% vs 47.6% today).
Cons
- Interest payments on debt are not well covered by earnings (EBIT is 1x annual interest expense, ideally 3x coverage).
- Sundaram Multi Pap's level of debt (47.6%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
Pros
- The tenure for the Sundaram Multi Pap board of directors is about average.
- Amrut's remuneration is about average for companies of similar size in India.
- Amrut's compensation has increased in line with Sundaram Multi Pap recently becoming profitable.
- The tenure for the Sundaram Multi Pap management team is about average.
Cons
misc
Pros
Cons
- Sundaram Multi Pap is not covered by any analysts.
past
Pros
- Sundaram Multi Pap's 1-year earnings growth exceeds its 5-year average (610.9% vs 55.3%)
- Sundaram Multi Pap has delivered over 20% year on year earnings growth in the past 5 years.
- Sundaram Multi Pap used its assets more efficiently than the IN Forestry industry average last year based on Return on Assets.
- Sundaram Multi Pap's earnings growth has exceeded the IN Forestry industry average in the past year (610.9% vs 4.1%).
Cons
- Sundaram Multi Pap's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Sundaram Multi Pap has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
Pros
- Sundaram Multi Pap's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Sundaram Multi Pap is good value based on assets compared to the IN Forestry industry average.
- SUNDARAM outperformed the Forestry industry which returned -48.1% over the past year.
- NSEI:SUNDARAM is up 13% outperforming the Forestry industry which returned 7.8% over the past month.
- NSEI:SUNDARAM is up 13% outperforming the market in India which returned 8% over the past month.
Cons
- Sundaram Multi Pap's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- Sundaram Multi Pap is overvalued based on earnings compared to the IN Forestry industry average.
- Sundaram Multi Pap is overvalued based on earnings compared to the India market.
- SUNDARAM underperformed the Market in India which returned -14.5% over the past year.